|
 |
|
ORIGINAL ARTICLE |
|
|
|
| Year : 2011 | Volume
: 36
| Issue : 2 | Page : 95-99 |
| |
An overview of radioactive waste disposal procedures of a nuclear medicine department
R Ravichandran1, JP Binukumar1, Rajan Sreeram2, LS Arunkumar3
1 Medical Physics Unit, National Oncology Center, Muscat, Sultanate of Oman
2 Royal Hospital, Muscat, Sultanate of Oman
3 DGEA, Ministry of Health, Muscat, Sultanate of Oman
| Date of Submission | 16-May-2010 |
| Date of Decision | 22-Jul-2010 |
| Date of Acceptance | 21-Sep-2010 |
| Date of Web Publication | 18-Apr-2011 |
Correspondence Address:
R Ravichandran
Medical Physics Unit, National Oncology Center, Royal Hospital, PB1331, PC 111, Muscat
Sultanate of Oman
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0971-6203.79692
 Abstract | | |
Radioactive wastes from hospitals form one of the various types of urban wastes, which are managed in developed countries in a safe and organized way. In countries where growth of nuclear medicine services are envisaged, implementations of existing regulatory policies and guidelines in hospitals in terms of handling of radioactive materials used in the treatment of patients need a good model. To address this issue, a brief description of the methods is presented. A designed prototype waste storage trolley is found to be of great help in decaying the I-131 solid wastes from wards before releasing to waste treatment plant of the city. Two delay tanks with collection time of about 2 months and delay time of 2 months alternately result in 6 releases of urine toilet effluents to the sewage treatment plant (STP) of the hospital annually. Samples of effluents collected at releasing time documented radioactive releases of I-131 much below recommended levels of bi-monthly release. External counting of samples showed good statistical correlation with calculated values. An overview of safe procedures for radioactive waste disposal is presented.
Keywords: Delay tanks, iodine-131, isolation wards, radioactive wastes
How to cite this article:
Ravichandran R, Binukumar J P, Sreeram R, Arunkumar L S. An overview of radioactive waste disposal procedures of a nuclear medicine department. J Med Phys 2011;36:95-9 |
How to cite this URL:
Ravichandran R, Binukumar J P, Sreeram R, Arunkumar L S. An overview of radioactive waste disposal procedures of a nuclear medicine department. J Med Phys [serial online] 2011 [cited 2023 Feb 6];36:95-9. Available from: https://www.jmp.org.in/text.asp?2011/36/2/95/79692 |
| Introduction | |  |
Medical applications of radioactive isotopes form one of the important peaceful uses of atomic energy. Unsealed radioactive isotopes are used in hospitals for diagnostic and therapeutic applications in various health disorders. Safe use of radioisotopes in medical applications is the main issue in obtaining clearance from national regulatory authorities. The important issues are 1) safe custody of the received radioisotopes, 2) surveillance for their safe applications in the department and 3) the disposal of the radioactive wastes generated from human use of these radioisotopes. The issues relating to management of radioactive wastes, are very well formulated internationally, and guidelines for radioactive waste disposal are well documented. [1],[2],[3],[4],[5],[6],[7],[8] The radioactive waste disposals must take into account permissible concentrations applicable from the standpoint of community safety, ensure that the degree of dilution envisaged is achieved at the discharge point (from the institution into the sewage system), and the hazard to the general population is insignificant in the event of the sludge containing radioactive waste material being used as fertilizer. Radioactive waste from nuclear medicine procedures can be dealt with either by simply storing the wastes safely till radioactive decay reduces the activity to a safe level or possibly by disposal of low-activity waste into the sewage system. A controlled disposal is defined as disposal with permission from the regulatory authority and appropriate monitoring. Oman being a newly formed member state under International Atomic Energy Agency (IAEA), there is a need for the local regulatory authority in Oman {Radiation Protection Adviser (RPA), Ministry of Health (MOH)} to review the records about the overall management of radioactive wastes. This paper outlines the various issues addressed by us in this regard.
| Materials and Methods | | |
Details of radioactivity handled
Radioactive sources received from GE Healthcare Buchler (Amersham, UK) or from Australia are used in this hospital only by the Department of Nuclear Medicine, which is located in the National Oncology Center complex of the hospital. Imaging procedures are carried out with Technicium-99m ( 99m Tc) formulations; and a limited number of procedures, using gallium-67 ( 67 Ga) and m-Iodobenzyl guanidine (MIBG) ( 131 I). The outlets of the toilets of the patients undergoing diagnostic procedures are connected to the delay tank meant for collection of radioactive iodine ( 131 I) from the isolation rooms meant for these treatments. Two isolation rooms are located in the oncology ward of the Royal Hospital.
The radioactive consignments are received from GE Health Care Buchler, Amersham, UK; or from Australia,; after the clearances for import of radioactive isotopes are obtained from the Ministry of Environment (MOE) and RPA, MOH. 131 I treatments have been started from February, 2006. Till the beginning of 2009, patients for the treatment of thyrotoxicosis received therapy as in-patients in the isolation rooms, in addition to the patients treated for postoperative thyroid carcinoma. These patients were discharged generally after 72 hours or after their exposure rates at distance of 1 metrefall below 10 μSv/h. Based on international recommendations, it is generally accepted that [4],[9] an amount of 45% and 90% of administered activity could be assumed to be present in the collected urine from patients of thyrotoxicosis and carcinoma thyroid, respectively, during their isolation period.
Waste management
Diagnostic wastes
Procedures for handling and disposal of wastes generated from diagnostic use of radioactive isotopes are described in the Royal Hospital document. [10] All 99m Tc daily wastes (disposables) are allowed to mix with normal wastes after a 48-hour delay. All wastes like used syringes and gloves are collected in plastic containers with dates of collection being recorded. Used syringes of 99m Tc, 67 Ga, 131 MIBG are generally put in different containers. Syringes for long - lived radioactive isotopes undergo minimum of 2-months decay before these are released after monitoring by the department's medical physicist using an end window Geiger Muller (GM) survey meter. Records of wastes released are maintained by the department. Details regarding any waste released to the Medical Wastes Treatment Plant (MWTP), MOH, Al Amerat, are entered in a pro-forma sheet, to be faxed with a copy to the RPA, MOH. Toilet wastes from diagnostic patients go into the delay tank to increase volume of therapeutic I-131 wastes from the isolation wards, thereby achieving higher dilution factor.
I-131 therapy wastes
Iodine-131 in the form of capsule is the only radioisotope presently used for therapy in Royal Hospital. Unused capsules are maintained safely in stores and an inventory is maintained. The generated solid wastes from the isolation wards (yellow and black bags) are labeled with patients' numbers and sent to a temporary storage trolley (TST), designed and fabricated locally for this purpose. TST is a lockable type [Figure 1] trolley and is kept well protected in the backyard of the hospital, and the contents are allowed to decay for 2 to 3 months before disposal. Individual bags are monitored by contamination monitor, certified and then disposed. The pro-forma sheet, described earlier is filled and faxed for the MWTP records.  | Figure 1: Temporary storage trolley in use for collection of solid wastes from I-131 wares in polythene bags. This trolley measurinig 1.20 x 0.85 x 0.80 m with castor wheels and locking facility, is anchored to the floor and is available at the waste collection yard, located behind the hospital premises
Click here to view |
Delay tanks
Liquid wastes (outlets from isolation room toilets) generated from 131 I administrations are collected in the delay tank. The principle of delay tank system for I-131 effluents is explained in [Figure 2]. Two isolation rooms have sewage connections to twin concrete tanks located in the garden area below ground level. Both the tanks have a size of 5 × 4 × 2 m each with 40 kL individual volumes. Total capacity of filling is 75% of volume, viz. 30 kL. Two submersible pumps are installed at 50 cm from the bottom of tanks. Level monitoring is done by ultrasound system. Float switches for monitoring effluent levels are kept at a height of 60 and 180 cm, respectively making the flush volume of delay tank system to be 24 kL. Business management system (BMS) shows percentage volume of effluents, along with a hooter alarm. An electronic control system exists at the engineering department to monitor the effluent levels in the delay tanks, status of opening - and closing of valves. Before the collected effluents are emptied, certification procedure is followed for filling of delay tanks, closing, clearing of the tanks. [11],[12] During filling phase of one tank, the other tank in filled condition decays for about 2 months. Documents for filling, closing, emptying, radioactivity monitoring in released effluents are maintained in the nuclear medicine and engineering departments. The operational guideline followed for maximum limit of discharge is 3.7 MBq /d or an average monthly concentration of 22.2 MBq /m 3 for I-131.  | Figure 2: Schematic view of iodine-131 isolation rooms 1 and 2 (B1, B2) and delay tanks D1 and D2. V1, V2 are inlet valves and V3, V4 are outlet valves (Details about volumes of delay tank and monitoring system have been given in the text)
Click here to view |
Procedure for release of delay tank effluents
Fifty milliliters of effluent sample is taken out from the delay tank which is due for release and checked by an end-window contamination monitor. Activity one milliliter of this sample is measured (counted) by single-channel analyzer spectrometer (Atom Lab, USA). One milliliter of delay tank sample and 1 mL of tap water are counted for 300 seconds by a Sodium Iodide (NaI) well counter at I-131 window. Each time, the well detector is calibrated by Cs-137 check source. The counting efficiency of the system is 30%. The measured excess counts over tap water sample are expressed as activity of the sample {disintegration per sec (dps)}.
| Results | | |
[Table 1] shows the total amount of activity (GBq) handled in the past. It can be seen from [Table 1] that activity of 131 I in 2009 increased by more than 50% as compared to the total activity used during 2008. [Table 2] shows the breakup of the details of administered activities of 131 I. In thyrotoxicosis treatments, the administered activities ranged from 479 to 627 MBq, with a mean of 574.7 ± 27.3 MBq (n= 50). For Ca. thyroid treatments, the used activities were in the range of 2.04 to 9.3 GBq, with a mean of 4.376±1.15 GBq (n= 70). It can be seen that in more number of patients, higher amount of activities (> 5 GBq) were administered. During the period 2006 - 2009, a total amount of 306.3 GBq (8,280 mCi) was administered in our hospital.
[Table 3] shows a representative collection phase at the delay tank no.2. The growths of I-131activity with time from the start of the tank filling, activity at the time of closing and activity remnant at the time of release of the tank are shown in this table. [Table 4] shows a summary of the number of days of filling, delay achieved till next tank filling, and the activity disposed. The estimated activity in released radioactive waste effluent from the delay tank, by gamma ray spectrometer well counting, agreed well (within 5 MBq tolerance in 17 out of 20 instances) with the activity obtained by theoretical calculation. During the month of June 2007, due to 'Gonu' cyclone, there was a sudden onset of heavy rains and there was need to release activity in 35 days instead of the usual 60 - 70 days.  | Table 3: Representation of activity growth in delay tank during one filling
Click here to view |
 | Table 4: Details of filling, delay phases and activity released from delay tank
Click here to view |
| Discussion | | |
We have reviewed the data on the waste disposal methods followed in Royal Hospital. All the details provided may be applied to any other similar hospital. The presence of decaying food material mixed in yellow bags and presence of radioactive tissues in black bags created difficulties in storing these bags in storage rooms in isolation wards. In a few occasions, there was infestation of fruit flies, leading to problems in the isolation wards, in turn resulting in problems related to new admissions of patients. The sanitary gauze containing blood, or 'breast-feeding-stopped patients' milk pads sometimes gave rise to high residual activity in waste bags, which needed more time to come to background level. As a remedy to this problem, we have come out with an innovative solution, viz. to have a TST as described earlier. The locally designed TST has provided a solution for storage of solid wastes, and insecticide spraying could be periodically undertaken.
From [Table 4], it can be observed that the amount of excretions indicated by the theoretical model correlates well (within 5 MBq tolerance in 17 out of 20 instances) to the released 131 I into sewage system. In 202 patients treated for Ca. thyroid with radioactive iodine, Driver and Packer [1] found that 55% of administered activity is excreted in first 24 hours and 85% of the administered activity is discharged in the sewer over a typical patient-stay period of 5 days. The need for maintaining proper pro-forma sheets by the Radiation Safety Officer (RSO), giving details of storage and disposal of radioactive waste, was highlighted by these authors. In view of our data, we would like to recommend that there is no need for laborious counting of effluent samples, and only the delay/decay patterns need to be followed, because all the details of administered activity and estimated activity released from patients are available.
The last column in [Table 4] indicates the actual amount of 131 I radioactive waste released from the institution during the period of 4 years (20 instances). For environmental departments and regulatory governmental authorities, this will provide an accurate account of radioactivity actually released into the sewage treatment plant. Such data of released waste activity against administered activity is not reported in any earlier studies found in literature. In a tank of 30 kL volume, the theoretically estimated activity being in agreement within 5 MBq (135 μCi) of counted activity indicates that theoretical approximation is reasonably accurate.
From [Table 4], it can also be observed that, mean delay time could not be extended for more than 60 days, because the other tank reaches its full capacity, necessitating release from it. There was an occasion during 'Gonu' cyclone in Oman, when there was onset of heavy rains and back pressure in toilets in isolation wards. This necessitated release of effluents within 35 days, and the counted 131 I in the effluents was at highest level: however it was less than 22 MBq/ m 3 operational limits. Recently IAEA has given a position statement - that there is no need for storage of urine in delay tanks and continuous sewage dilutions are sufficient. [13] However, in most of the places in the Middle East Asian countries, there are no centralized sewage management systems connected to hospitals and therefore such delay tanks appear to have a role in the management of radioactive urine in such places.
The main objective of this report is to highlight that the kinetic model of activity released from patients seems to be reasonably accurate; therefore, it appears that we can as well do away with laborious counting of inspection samples each time. This paper also documents that the released radioactive wastes were much below permitted activity levels of 22 MBq/ m 3 for 131 I{ (maximum released 131 I activity 145.8 MBq / 36 m 3)(4.5 MBq /m 3) in the last 4 years, which will reduce concern among the general public about released radioactive wastes from hospitals.
| Acknowledgements | | |
The authors thank the Director General of Royal Hospital; and Head, Department of Nuclear Medicine, Royal Hospital, for the kind permission for publication of this report. The fabrication work of metal storage trolley by the Engineering Department, Royal Hospital, is gratefully acknowledged.
| References | | |
| 1. | Driver I, Packer S. Radioactive waste discharge quantities for patients undergoing radioactive iodine therapy for thyroid carcinoma. Nucl Med Comm 2001;22:1129-32. 
|
| 2. | Leung PM, Nikolic M. Disposal of therapeutic 131-I waste using a multiple holding tank system. Health Phys 1998;10:315-21.
|
| 3. | Ravichandran R, Pant GS. Storage and disposal of radioactive waste. In: Pant GS, editor. Radiation Safety of Unsealed Sources. 2 nd ed. Mumbai: Himalaya Pub. Co; 2000. p. 237-48.
|
| 4. | Ravichandran R. Storage and disposal of radioactive waste. In: Pant GS, editor. Radiation safety for unsealed sources. 1 nd ed. Mumbai: Himalaya Pub. Co; 1998. p. 102-14.
|
| 5. | Ravichandran R, Jayasree U, Supe SS, Keshava SL, Devaru S. Abstract P 42.23 rd IARP Conf. Recent Advances in Radiation Measurements and Radiation Protection, Amristar, Feb. 1997.
|
| 6. | Soman SD, Venkateshwaran TV.Radiological protection aspects of radionuclide therapy for cancer of the thyroid.Proc. of Seminar, Bombay, 4-6 March 1998, BARC, Bombay.Sponsored by BARC and WHO; 1998. p. 195-202.
|
| 7. | Radioactive waste disposal.In Text Book of Radiological Safety. In: Thayalan K, editor. Chennai: Jaypee Med Publication; 2010. p. 267-88.
|
| 8. | Applying radiation safety standards in Nuclear Medicine. Safety Reports Series No.40, Vienna: IAEA; 2005.
|
| 9. | Dendy PP, Palmer KE, Szaz KF. Radiation Protection-Disposal of waste.Ch.7. In: Sharp PF, Gemmell HG, Smith FW, editors. Practical Nuclear Medicine. Oxford: IRL Press; 1989. p. 91-107.
|
| 10. | Infection Control Policies and Procedures.The Infection Control Committee, Royal Hospital, 2001. p. 147-9.
|
| 11. | Ravichandran R, Arunkumar LS, Sreeram R, Gorman K, Saadi AA. Design, function and radiation safety aspects of delay tank system connected to radioactive iodine isolation wards at oncology center, Oman. J Med Phys 2006;31:156-7.
|
| 12. | Ravichandran R, Binukumar JP, Sreeram R, Arunkumar LS.Proc. AMPICON; Hyderabad, 2000. p. 101-2.
|
| 13. | IAEA position statement.Release of patients after radionuclide therapy, 2010.
|
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4]
| This article has been cited by | | 1 |
Assessment of total annual effective doses to representative person, for authorised and accidental releases from the Nuclear Medicine Department at Cattinara Hospital (Trieste, Italy) |
|
| Michele Signoriello, Maria Rosa Fornasier, Mario de Denaro, Fulvia Arfelli, Benedetta Santoro, Mara Severgnini | | Physica Medica. 2022; 102: 88 | | [Pubmed] | [DOI] | | | 2 |
Preparation and structure analyses of Sn-bentonite for pertechnetate removal |
|
| Eszter Mária Kovács, Dóra Buzetzky, Márton Soha, Tamás Fodor, Péter Kónya, Sándor Stichleutner, Shiro Kubuki, Erno Kuzmann, József Kónya, Noémi M. Nagy | | Process Safety and Environmental Protection. 2022; 168: 133 | | [Pubmed] | [DOI] | | | 3 |
Radioactive Decontamination using Bamboo Activated Carbon for Healthy Environment in Nuclear Medicine |
|
| R Sunaiwi, M K A Abdul Razab, N M Nawi, A T Khaizul, M A Azhar, N Y Samsuddin, S I Shukri, A Mohamed Noor, N H Abdullah, A Mohammed, Z Abdul [email protected], Z Hamzah | | IOP Conference Series: Earth and Environmental Science. 2022; 1102(1): 012001 | | [Pubmed] | [DOI] | | | 4 |
Design, Commissioning and Operation of Programmable Drainage System for PET-CT: An Optimized Approach to Protect Personnel and Environment in Nuclear Medicine Facilities |
|
| Mostafa M Elashmawy | | Radiation Protection Dosimetry. 2022; | | [Pubmed] | [DOI] | | | 5 |
Discharges of Nuclear Medicine Radioisotopes: The Impact of an Abatement System |
|
| Nathaly Barbosa, Lorena Sandoval Castillo, Juan Sebastián Quimbayo | | Health Physics. 2022; 122(5): 586 | | [Pubmed] | [DOI] | | | 6 |
Screening of New bio-based materials for radioactive iodide adsorption from water environment |
|
| Jakkapon Phanthuwongpakdee, Sandhya Babel, Tatsuo Kaneko | | Journal of Water Process Engineering. 2021; 40: 101955 | | [Pubmed] | [DOI] | | | 7 |
131I and 99mTc in Effluents from a Nuclear Medicine Facility and Associated Sewage Treatment Unit |
|
| Alessander Sá do Carmo, Elizabeth Aparecida Vianello, Wagner Pereira, Evangelina Marcia Lima de Macędo, Lucas Gomes Padilha Filho, Sérgio Augusto Lopes de Souza, Ademir Xavier da Silva | | Water, Air, & Soil Pollution. 2021; 232(4) | | [Pubmed] | [DOI] | | | 8 |
Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies |
|
| Suresh Subramanian, Madhava B. Mallia, Ajit S. Shinto, Ashwathy S. Mathew | | Oncology and Therapy. 2021; 9(2): 273 | | [Pubmed] | [DOI] | | | 9 |
Anthocyanin based agricultural wastes as bio-adsorbents for scavenging radioactive iodide from aqueous environment |
|
| Jakkapon Phanthuwongpakdee, Sandhya Babel, Kritapas Laohhasurayotin, Suchinda Sattayaporn, Tatsuo Kaneko | | Journal of Environmental Chemical Engineering. 2020; 8(5): 104147 | | [Pubmed] | [DOI] | | | 10 |
Preliminary Study of the Potential Graphene Oxide as Radioactive Clinical Wastewater Adsorbability in Nuclear Medicine |
|
| Mohammad Khairul Azhar Abdul Razab, Mohd Syahir Manso, An’amt Mohamed Noor, Suhanis Mohd Rozi, Nur Fatin Fariha Abd Latif, Khairul Nizam Jaafar, Farakhdina Jamaludin | | IOP Conference Series: Earth and Environmental Science. 2020; 596: 012037 | | [Pubmed] | [DOI] | | | 11 |
Characterization of GO:I-131 for Radioactive Clinical Waste Water Management in Nuclear Medicine |
|
| Mohammad Khairul Azhar Abdul Razab, Mohd Syahir Mansor, An'amt Mohamed Noor, Nur Fatin Fariha Abd Latif, Suhanis Mohamad Rozi, Khairul Nizam Jaafar, Farakhdina Jamaludin | | Materials Science Forum. 2020; 1010: 561 | | [Pubmed] | [DOI] | | | 12 |
Tuning the Nature of the Anion in Hydrated Layered Double Hydroxides for H2 Production under Ionizing Radiation |
|
| Maxime Lainé, Yuanyuan Liao, Fanny Varenne, Pierre Picot, Laurent J. Michot, Elodie Barruet, Valérie Geertsen, Antoine Thill, Manuel Pelletier, Jean-Blaise Brubach, Pascale Roy, Sophie Le Caër | | ACS Applied Nano Materials. 2018; 1(9): 5246 | | [Pubmed] | [DOI] | | | 13 |
Measurement and Estimation for the Clearance of Radioactive Waste with Patients of Thyroid Treatment |
|
| Chang-Bum Kim,Seong-Joo Jang | | The Journal of the Korea Contents Association. 2014; 14(6): 255 | | [Pubmed] | [DOI] | | | 14 |
Measurement and Estimation for the Clearance of Radioactive Waste Contaminated with Radioisotopes for Medical Application |
|
| Changbum Kim,MinSeok Park,Gi-sub Kim,Haijo Jung,Seongjoo Jang | | Progress in Medical Physics. 2014; 25(1): 8 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
